{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:40:07Z","timestamp":1792676407176,"version":"4.5.0"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:00:00Z","timestamp":1536883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIFA-USDA"},{"name":"NIFA-USDA"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0203771","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T17:48:15Z","timestamp":1536947295000},"page":"e0203771","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus"],"prefix":"10.1371","volume":"13","author":[{"given":"Jianping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7869-9806","authenticated-orcid":true,"given":"Zeinab H.","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Karch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Girshick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Garmendia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Burkhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazhar I.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,9,14]]},"reference":[{"key":"ref1","first-page":"101","article-title":"Infectious bronchitis","volume":"11","author":"D Cavanagh","year":"2003","journal-title":"Diseases of poultry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2307\/1592697","article-title":"The early history of infectious bronchitis","volume":"42","author":"J Fabricant","year":"1998","journal-title":"Avian Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3382\/ps.0632358","article-title":"Nephropathogenicity of infectious bronchitis virus","volume":"63","author":"RW Winterfield","year":"1984","journal-title":"Poult Sci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2307\/1591546","article-title":"Escherichia coli multiplication and lesions in the respiratory tract of chickens inoculated with infectious bronchitis virus and\/or E. coli","author":"K Nakamura","year":"1992","journal-title":"Avian Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1016\/j.vaccine.2006.06.040","article-title":"Safety and efficacy of an infectious bronchitis virus used for chicken embryo vaccination","volume":"24","author":"I Tarpey","year":"2006","journal-title":"Vaccine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.vaccine.2008.01.006","article-title":"Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination","volume":"26","author":"ET McKinley","year":"2008","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.1217134","article-title":"Attenuated vaccines can recombine to form virulent field viruses","volume":"337","author":"SW Lee","year":"2012","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.vaccine.2010.01.062","article-title":"Characterization of a novel live attenuated infectious bronchitis virus vaccine candidate derived from a Korean nephropathogenic strain","volume":"28","author":"HJ Lee","year":"2010","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0145-305X(99)00072-5","article-title":"Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry","volume":"24","author":"EW Collisson","year":"2000","journal-title":"Developmental & Comparative Immunology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1637\/0005-2086(2002)046[0938:POCALA]2.0.CO;2","article-title":"Protection of chickens after live and inactivated virus vaccination against challenge with nephropathogenic infectious bronchitis virus PA\/Wolgemuth\/98","volume":"46","author":"B Ladman","year":"2002","journal-title":"Avian Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/CMR.00005-07","article-title":"Current status of veterinary vaccines","volume":"20","author":"EN Meeusen","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jviromet.2008.01.017","article-title":"Enhancement of the immunogenicity of an infectious bronchitis virus DNA vaccine by a bicistronic plasmid encoding nucleocapsid protein and interleukin-2","volume":"149","author":"M Tang","year":"2008","journal-title":"J Virol Methods"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1586\/erv.09.160","article-title":"Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists","author":"M Black","year":"2010"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.4049\/jimmunol.0901957","article-title":"A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria","volume":"183","author":"SA Kaba","year":"2009","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1747-0285.2008.00746.x","article-title":"Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine","volume":"73","author":"TA Pimentel","year":"2009","journal-title":"Chemical biology & drug design"},{"key":"ref16","first-page":"126794","article-title":"A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection","volume":"2011","author":"S Babapoor","year":"2011","journal-title":"Influenza Res Treat"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e48304","DOI":"10.1371\/journal.pone.0048304","article-title":"Protective antibody and CD8 T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine","volume":"7","author":"SA Kaba","year":"2012","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1747-0285.2012.01423.x","article-title":"Conformation\u2010specific Display of 4E10 and 2F5 Epitopes on Self\u2010assembling Protein Nanoparticles as a Potential HIV Vaccine","volume":"80","author":"N Wahome","year":"2012","journal-title":"Chemical biology & drug design"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.vaccine.2014.03.092","article-title":"Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice","volume":"32","author":"K El Bissati","year":"2014","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e0143071","DOI":"10.1371\/journal.pone.0143071","article-title":"A novel virus-like particle based vaccine platform displaying the placental malaria antigen VAR2CSA","volume":"10","author":"S Thrane","year":"2015","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.nano.2016.08.030","article-title":"Vaccination with self-adjuvanted protein nanoparticles provides protection against lethal influenza challenge","volume":"13","author":"CP Karch","year":"2017","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"L Zhao","year":"2014","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41541-017-0024-6","article-title":"Protein nanovaccine confers robust immunity against Toxoplasma","volume":"2","author":"K El Bissati","year":"2017","journal-title":"NPJ Vaccines"},{"key":"ref24","article-title":"Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum circumsporozoite protein delivered in three army liposome formulation adjuvants","author":"L Seth","year":"2017","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.vaccine.2017.12.001","article-title":"Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccine","volume":"36","author":"S. A. Kaba","year":"2018","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3527(08)60286-9","article-title":"The molecular biology of coronaviruses","volume":"48","author":"MM Lai","year":"1997","journal-title":"Adv Virus Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"S Belouzard","year":"2012","journal-title":"Viruses"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.virusres.2014.10.009","article-title":"The avian coronavirus spike protein","volume":"194","author":"IA Wickramasinghe","year":"2014","journal-title":"Virus Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1099\/0022-1317-67-7-1435","article-title":"Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection","volume":"67","author":"D Cavanagh","year":"1986","journal-title":"J Gen Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jmb.2009.10.032","article-title":"Identification of a new region of SARS-CoV S protein critical for viral entry","volume":"394","author":"Y Guo","year":"2009","journal-title":"J Mol Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/S0264-410X(03)00227-5","article-title":"A recombinant fowl adenovirus expressing the S1 gene of infectious bronchitis virus protects against challenge with infectious bronchitis virus","volume":"21","author":"MA Johnson","year":"2003","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2008.09.125","article-title":"The immunoreactivity of a chimeric multi-epitope DNA vaccine against IBV in chickens","volume":"377","author":"L Tian","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3923\/ijps.2009.1034.1041","article-title":"Protective effect of In ovo vaccination with IBV-spike-recombinant DNA and chicken interferon as an adjuvant","volume":"11","author":"S Babapoor","year":"2009","journal-title":"Int.J.Poult.Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1271\/bbb.120521","article-title":"Comparative dynamic distribution of avian infectious bronchitis virus M41, H120, and SAIBK strains by quantitative real-time RT-PCR in SPF chickens","volume":"76","author":"W Fan","year":"2012","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref35","first-page":"403","article-title":"Pathogenicity of infectious bronchitis virus isolates from Ontario chickens","volume":"72","author":"H Grgic","year":"2008","journal-title":"Canadian journal of veterinary research"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1017\/S0043933914000385","article-title":"An overview of infectious bronchitis virus in chickens","volume":"70","author":"F Awad","year":"2014","journal-title":"Worlds Poult Sci J"},{"key":"ref37","first-page":"424860","article-title":"Progress and challenges toward the development of vaccines against avian infectious bronchitis","author":"F Bande","year":"2015","journal-title":"J Immunol Res"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/03079459994506","article-title":"Breadth of Protection of the Respiratory Tract Provided by Different Live-Attenuated Infectious Bronchitis Vaccines Against Challenge with Infectious Bronchitis Viruses of Heterologous Serotypes","volume":"28","author":"JKA Cook","year":"1999","journal-title":"Avian Pathology"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/03079459008418700","article-title":"Comparison of the Susceptibility to Avian Infectious Bronchitis Virus Infection of Two Inbred Lines of White Leghorn Chickens","volume":"19","author":"K Otsuki","year":"1990","journal-title":"Avian Pathology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/104303401750148748","article-title":"Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice","volume":"12","author":"L Mohr","year":"2001","journal-title":"Hum Gene Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/smll.200900466","article-title":"Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage","volume":"5","author":"Y Pan","year":"2009","journal-title":"Small"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2478\/v10019-011-0037-0","article-title":"Titanium dioxide in our everyday life; is it safe?","volume":"45","author":"M Skocaj","year":"2011","journal-title":"Radiology and oncology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.nantod.2011.10.001","article-title":"Toxicology and clinical potential of nanoparticles","volume":"6","author":"L Yildirimer","year":"2011","journal-title":"Nano today"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0962-8924(00)01898-5","article-title":"Coiled coils: a highly versatile protein folding motif","volume":"11","author":"P. Burkhard","year":"2001","journal-title":"Trends Cell Biol"},{"issue":"18","key":"ref45","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.vaccine.2017.03.045","article-title":"Recombinant Newcastle Disease Virus Expressing the Infectious Bronchitis Virus S1 Gene Protects Chickens Against Newcastle Disease Virus and Infectious Bronchitis Virus Challenge","volume":"35","author":"R Zhao","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1099\/0022-1317-79-4-719","article-title":"Induction of Protective Immunity in Chickens Vaccinated with Infectious Bronchitis Virus S1 Glycoprotein Expressed by a Recombinant Baculovirus","volume":"79","author":"CS Song","year":"1998","journal-title":"Journal of General Virology"},{"issue":"21\u201322","key":"ref47","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/S0264-410X(03)00227-5","article-title":"A Recombinant Fowl Adenovirus Expressing the S1 Gene of Infectious Bronchitis Virus Protects Against Challenge with Infectious Bronchitis Virus","volume":"21","author":"MA Johnson","year":"2003","journal-title":"Vaccine"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1128\/JVI.64.11.5367-5375.1990","article-title":"Assembly of coronavirus spike protein into trimers and its role in epitope expression","volume":"64","author":"B Delmas","year":"1990","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"19727","DOI":"10.1074\/jbc.M201837200","article-title":"Quaternary structure of coronavirus spikes in complex with carcinoembryonic antigen-related cell adhesion molecule cellular receptors","volume":"277","author":"DN Lewicki","year":"2002","journal-title":"J Biol Chem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.vaccine.2006.08.011","article-title":"Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate Fc\u03b3RII-dependent entry into B cells in vitro","volume":"25","author":"YW Kam","year":"2007","journal-title":"Vaccine"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1016\/j.vaccine.2006.01.059","article-title":"A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice","volume":"24","author":"Z Zhou","year":"2006","journal-title":"Vaccine"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1089\/vim.2012.0076","article-title":"Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates","volume":"26","author":"J Li","year":"2013","journal-title":"Viral Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4142\/jvs.2014.15.2.209","article-title":"Production and immunogenicity of chimeric virus-like particles containing the spike glycoprotein of infectious bronchitis virus","volume":"15","author":"L Lv","year":"2014","journal-title":"Journal of veterinary science"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.vaccine.2013.12.006","article-title":"BacMam virus-based surface display of the infectious bronchitis virus (IBV) S1 glycoprotein confers strong protection against virulent IBV challenge in chickens","volume":"32","author":"J Zhang","year":"2014","journal-title":"Vaccine"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00705-005-0541-x","article-title":"Identification of previously unknown antigenic epitopes on the S and N proteins of avian infectious bronchitis virus","volume":"150","author":"J Ignjatovic","year":"2005","journal-title":"Arch Virol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1016\/j.vaccine.2017.09.013","article-title":"Protection against infectious bronchitis virus by spike ectodomain subunit vaccine","volume":"35","author":"F Eldemery","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/03079459208418816","article-title":"Location of the Amino Acid Differences in the S1 Spike Glycoprotein Subunit of Closely Related Serotypes of Infectious Bronchitis Virus","volume":"21","author":"D Cavanagh","year":"1992","journal-title":"Avian Pathology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex","volume":"77","author":"BJ Bosch","year":"2003","journal-title":"J Virol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.8248784","article-title":"The influence of antigen organization on B cell responsiveness","volume":"262","author":"MF Bachmann","year":"1993","journal-title":"Science"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.1128\/JVI.00549-15","article-title":"Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates","volume":"89","author":"JR Kim","year":"2015","journal-title":"J Virol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1016\/j.vaccine.2011.05.001","article-title":"Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza\u2013flagellin fusion vaccine (VAX125, STF2. HA1 SI)","volume":"29","author":"DN Taylor","year":"2011","journal-title":"Vaccine"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"e0148701","DOI":"10.1371\/journal.pone.0148701","article-title":"Flagellin encoded in gene-based vector vaccines is a route-dependent immune adjuvant","volume":"11","author":"HF Rady","year":"2016","journal-title":"PloS one"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0203771","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T22:28:30Z","timestamp":1604960910000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0203771"}},"subtitle":[],"editor":[{"given":"Paulo Lee","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":62,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0203771","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,14]]}}}